Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Melanoma Research
|
January 29, 2020
Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
Thijs T Wind, Ranko Gacesa, Arnau Vich Vila, et al.
Cancer Medicine
|
November 6, 2021
Value of screening and follow-up brain MRI scans in patients with metastatic melanoma
Annemarie C Eggen, Thijs T Wind, Ingeborg Bosma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2019
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program
Cornelis Bisschop, Thijs T Wind, Christian U Blank, et al.
Cancer Metastasis Reviews
|
May 6, 2020
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
Pieter A Boonstra, Thijs T Wind, Michel van Kruchten, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 2, 2021
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
Pim P van de Donk, Thijs T Wind, Jahlisa S Hooiveld-Noeken, et al.
Oncoimmunology
|
February 7, 2019
A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma
Thijs T Wind, Mathilde Jalving, Jacco J de Haan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2019
<sup>89</sup>Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
Kirsten L Moek, Stijn J H Waaijer, Iris C Kok, et al.
Cancers
|
June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
Olivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
Nature Medicine
|
February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Melanoma Research
|
January 29, 2020
Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
Thijs T Wind, Ranko Gacesa, Arnau Vich Vila, et al.
Cancer Medicine
|
November 6, 2021
Value of screening and follow-up brain MRI scans in patients with metastatic melanoma
Annemarie C Eggen, Thijs T Wind, Ingeborg Bosma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 31, 2019
Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program
Cornelis Bisschop, Thijs T Wind, Christian U Blank, et al.
Cancer Metastasis Reviews
|
May 6, 2020
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
Pieter A Boonstra, Thijs T Wind, Michel van Kruchten, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 2, 2021
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
Pim P van de Donk, Thijs T Wind, Jahlisa S Hooiveld-Noeken, et al.
Oncoimmunology
|
February 7, 2019
A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma
Thijs T Wind, Mathilde Jalving, Jacco J de Haan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2019
<sup>89</sup>Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake
Kirsten L Moek, Stijn J H Waaijer, Iris C Kok, et al.
Cancers
|
June 10, 2023
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
Olivier J van Not, Thijs T Wind, Rawa K Ismail, et al.
Nature Medicine
|
February 16, 2024
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R Björk, Laura A Bolte, Andrew Maltez Thomas, et al.
Page
of 1